Source comparison
TB-500 Dosing Protocols: Acute Injury vs Chronic Repair
Dosing TB-500 for acute muscle injury follows a front-loading protocol: higher frequency during the inflammatory phase (days 0–14) followed by lower maintenance dosing during the remodeling phase (weeks 3–8). The standard acute protocol documented in veterinar
This comparison does not assign a generated winner or score.
- Dosing TB-500 for acute muscle injury follows a front-loading protocol: higher frequency during the inflammatory phase (days 0–14) followed by lower maintenance dosing during the remodeling phase (weeks 3–8). The standard acute protocol documented in veterinary and rodent studies is 2–2.5mg subcutaneously twice weekly for two weeks, then 2mg weekly for four weeks. This schedule aligns with the natural tissue repair timeline: inflammation peaks at 48–72 hours, proliferation occurs from days 3–21, and remodeling continues for 6–12 weeks depending on injury severity.
- Chronic injuries. Tendinopathies, persistent strains, or scar tissue from old trauma. Respond differently. Chronic tissue has completed the inflammatory phase and entered a low-grade degenerative state characterized by collagen disorganization and reduced vascularity. TB-500 can still promote angiogenesis in chronic injuries, but the actin migration effect is minimal because satellite cells are no longer actively proliferating. Protocols for chronic conditions typically use 2mg weekly for 8–12 weeks, combined with mechanical loading (physical therapy, eccentric exercise) to stimulate tissue turnover.
- A critical dosing mistake: administering TB-500 systemically (intramuscularly or subcutaneously distant from the injury site) versus locally (perilesional injection). Local administration concentrates the peptide at the injury site but requires precise anatomical knowledge and sterile technique. Most research uses systemic subcutaneous injection because it's reproducible and still delivers measurable results through circulatory distribution.
- Research-grade peptides require reconstitution with bacteriostatic water. Lyophilized TB-500 stored at −20°C maintains stability for 24+ months, but once reconstituted, the peptide must be refrigerated at 2–8°C and used within 28 days. Temperature excursions above 8°C cause irreversible peptide degradation that neither visual inspection nor home testing can detect.